Roy R. Teller

Array ( [id] => 8197084 [patent_doc_number] => 20120121612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'FERMENTED WHEAT GERM PROTEINS (FWGP) FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/320898 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19524 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121612.pdf [firstpage_image] =>[orig_patent_app_number] => 13320898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056047 [patent_doc_number] => 20120077755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Compounds For, and Methods of, Treating Cancer and Inhibiting Invasion and Metastases' [patent_app_type] => utility [patent_app_number] => 13/319476 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8960 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077755.pdf [firstpage_image] =>[orig_patent_app_number] => 13319476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6513728 [patent_doc_number] => 20100216692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Acidic Insulin Preparations Having Improved Stability' [patent_app_type] => utility [patent_app_number] => 12/773356 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4372 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216692.pdf [firstpage_image] =>[orig_patent_app_number] => 12773356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511389 [patent_doc_number] => 20110257099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Use of Natriuretic Peptide for Treating Heart Failure' [patent_app_type] => utility [patent_app_number] => 12/767395 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16126 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257099.pdf [firstpage_image] =>[orig_patent_app_number] => 12767395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10142238 [patent_doc_number] => 09175037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Neuromedin U derivative' [patent_app_type] => utility [patent_app_number] => 13/263630 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 23 [patent_no_of_words] => 20054 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186301 [patent_doc_number] => 20110124583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Methods and Compositions for the Treatment of Gastrointestinal Disorders' [patent_app_type] => utility [patent_app_number] => 12/754138 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22432 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124583.pdf [firstpage_image] =>[orig_patent_app_number] => 12754138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236293 [patent_doc_number] => 20100267638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'EXOSITE-DIRECTED THROMBIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/720068 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17903 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267638.pdf [firstpage_image] =>[orig_patent_app_number] => 12720068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506946 [patent_doc_number] => 20100210560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'NEUROTENSIN RECEPTOR AGONISTS AND OPIOID RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/714476 [patent_app_country] => US [patent_app_date] => 2010-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8555 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210560.pdf [firstpage_image] =>[orig_patent_app_number] => 12714476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295164 [patent_doc_number] => 20100160210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'GUANIDINIUM DELIVERY CARRIERS' [patent_app_type] => utility [patent_app_number] => 12/710320 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16169 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160210.pdf [firstpage_image] =>[orig_patent_app_number] => 12710320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056017 [patent_doc_number] => 20120077746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'GLP-1 ANALOGUES PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/148638 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17734 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077746.pdf [firstpage_image] =>[orig_patent_app_number] => 13148638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784662 [patent_doc_number] => 20120046218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'GLYCOSAMINOGLYCAN-ANTAGONISING MCP-I MUTANTS AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 13/145217 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6832 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046218.pdf [firstpage_image] =>[orig_patent_app_number] => 13145217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296731 [patent_doc_number] => 20100160610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Conjugates of an EPO Moiety and a Polymer' [patent_app_type] => utility [patent_app_number] => 12/691666 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23998 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160610.pdf [firstpage_image] =>[orig_patent_app_number] => 12691666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596993 [patent_doc_number] => 20100292158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Compositions and Methods for Enhanced Pharmacological Activity of Compositions Comprising Peptide Drug Substances' [patent_app_type] => utility [patent_app_number] => 12/687982 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4512 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292158.pdf [firstpage_image] =>[orig_patent_app_number] => 12687982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6634982 [patent_doc_number] => 20100226852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'CLK-PEPTIDE AND SLK-PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/643926 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20003 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226852.pdf [firstpage_image] =>[orig_patent_app_number] => 12643926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511380 [patent_doc_number] => 20110257090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'SOLUTIONS FOR VOLUME THERAPY' [patent_app_type] => utility [patent_app_number] => 13/131318 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5894 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257090.pdf [firstpage_image] =>[orig_patent_app_number] => 13131318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10606989 [patent_doc_number] => 09327008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Cell-permeant peptide-based inhibitor of kinases' [patent_app_type] => utility [patent_app_number] => 12/634476 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 50230 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12634476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756690 [patent_doc_number] => 20120028897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF FLUID RETENTION DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/132262 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12813 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028897.pdf [firstpage_image] =>[orig_patent_app_number] => 13132262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685444 [patent_doc_number] => 20100120697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Tumor Activated Prodrugs' [patent_app_type] => utility [patent_app_number] => 12/613357 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9063 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120697.pdf [firstpage_image] =>[orig_patent_app_number] => 12613357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490775 [patent_doc_number] => 08030269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Calcitonin drug-oligomer conjugates, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/606455 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17407 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030269.pdf [firstpage_image] =>[orig_patent_app_number] => 12606455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953861 [patent_doc_number] => 20110034389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'ACTIVE AGENTS, COMPOSITIONS, AND METHODS FOR INHIBITING AND REVERSING PLATELET FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/667119 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 13328 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 63 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034389.pdf [firstpage_image] =>[orig_patent_app_number] => 12667119 [rel_patent_id] =>[rel_patent_doc_number] =>)